CN109970703A - 1,3-杂环取代芳香酮的制备方法及应用 - Google Patents
1,3-杂环取代芳香酮的制备方法及应用 Download PDFInfo
- Publication number
- CN109970703A CN109970703A CN201910380476.5A CN201910380476A CN109970703A CN 109970703 A CN109970703 A CN 109970703A CN 201910380476 A CN201910380476 A CN 201910380476A CN 109970703 A CN109970703 A CN 109970703A
- Authority
- CN
- China
- Prior art keywords
- substituted aromatic
- heterocyclic substituted
- preparation
- phenylacetic acid
- heterocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000008365 aromatic ketones Chemical class 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 36
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims abstract description 23
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 13
- 229960003424 phenylacetic acid Drugs 0.000 claims abstract description 13
- 239000003279 phenylacetic acid Substances 0.000 claims abstract description 13
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 125000003118 aryl group Chemical group 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 8
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims abstract description 5
- 238000004440 column chromatography Methods 0.000 claims abstract description 5
- 239000003472 antidiabetic agent Substances 0.000 claims abstract description 4
- 239000004020 conductor Substances 0.000 claims abstract description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims 2
- 239000000706 filtrate Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 229940126904 hypoglycaemic agent Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 230000005693 optoelectronics Effects 0.000 abstract description 4
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 238000001308 synthesis method Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N N,N′-Dicyclohexylcarbodiimide Substances C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- QOYNPSVOHUTODU-UHFFFAOYSA-N 2,4-dimethyl-2,4-di(thiophen-3-yl)pentan-3-one Chemical compound C1=CSC=C1C(C)(C)C(=O)C(C)(C)C=1C=CSC=1 QOYNPSVOHUTODU-UHFFFAOYSA-N 0.000 description 1
- RCNOGGGBSSVMAS-UHFFFAOYSA-N 2-thiophen-3-ylacetic acid Chemical compound OC(=O)CC=1C=CSC=1 RCNOGGGBSSVMAS-UHFFFAOYSA-N 0.000 description 1
- -1 3-(2,3-Dimethyl-3-(thiophen-3-yl)but-2-yl)thiophene Chemical compound 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000012776 electronic material Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000012229 microporous material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000015843 photosynthesis, light reaction Effects 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1,3‑杂环取代芳香酮的制备方法及应用,属于医药技术及光电材料领域。本发明以杂环取代的芳香苯乙酸为原料和DCC和DMAP在二氯甲烷体系反应得到化合物,化学物使用柱层析提纯得到最终产品,该产品可以用在降糖药和光电结晶导体材料的制备。本发明使用杂环取代的芳香苯乙酸反应制备1,3‑杂环取代芳香酮;反应操作简单易行,在温和反应条件下进行。本发明提供的合成方法简单易行、科学合理、绿色环保、经济实用,适合规模化生产。
Description
技术领域
本发明涉及医药技术及光电材料领域,主要涉及1,3-杂环取代芳香酮的制备方法及应用。
背景技术
1,3-杂环取代芳香酮由于其独特的分子结构、光电特性以及它们在p-电子材料上的应用,使其在微孔材料、结晶光电导体、合成石墨烯片段等方面的应用越来越广泛。同时,1,3-杂环取代芳香酮可作为一种廉价的前体,快速有效地制备相对复杂的构造物,所以在药物合成方面也有重要应用。基于此,本领域需要更加简便、绿色、经济的方法来合成1,3-杂环取代芳香酮。本发明使用杂环取代的芳香苯乙酸的反应制备1,3-杂环取代芳香酮。反应操作简单易行,在温和反应条件下进行。本发明提供的合成方法简单易行、科学合理、绿色环保、经济实用,适合规模化生产。
发明内容
为弥补现有技术的不足,本发明提供了操作简单易行、温和条件下合成1,3-杂环取代芳香酮的方法。
本发明采用如下技术方案:1,3-杂环取代芳香酮,具有如式Ⅰ所示的结构:
本发明的目的是请求保护上述1,3-杂环取代芳香酮的制备方法,即:将DCC(N,N'-二环己基碳酰亚胺)和DMAP(4-二甲氨基吡啶)按照摩尔比为1~10:1~2加入到圆底烧瓶中,并加入干燥的二氯甲烷(1mmol:(2~5mL))至搅拌均匀。将杂环取代的芳香苯乙酸(摩尔数与DCC相等)溶解在(1mmol:(4~8mL))干燥的二氯甲烷溶液中,采用恒压滴液漏斗滴加至反应液中,在温度为20~30℃反应24-72h,随着反应的进行溶液的颜色变为橙色,过滤出沉淀,之后进行旋蒸。采用柱层析分离得到化合物(洗脱剂为乙酸乙酯:石油醚=1:5)。
所述的二氯甲烷的体积数均是以杂环取代的芳香苯乙酸的摩尔量为标准的。
优选的,所述的杂环取代的芳香苯乙酸为:
本发明同时请求保护上述1,3-杂环取代芳香酮在药物制备及光电材料领域上的应用。
比如用于降糖药中间体或光电结晶导体材料的制备。
与现有技术相比,本发明的有益效果是:
本发明使用杂环取代的芳香苯乙酸反应制备1,3-杂环取代芳香酮;反应操作简单易行,在温和反应条件下进行。本发明提供的合成方法简单易行、科学合理、绿色环保、经济实用,适合规模化生产。
具体实施方式
下面通过具体实施例详述本发明,但不限制本发明的保护范围。如无特殊说明,本发明所采用的实验方法均为常规方法,所用实验器材、材料、试剂等均可从化学公司购买。
实施例1
取一个100mL圆底烧瓶,将DCC(1.0320g,5mmol)和DMAP(0.1222g,1mmol)加入10mL干燥的的二氯甲烷中,搅拌至全部溶解。将3-噻吩乙酸(0.7109g,5mmol)溶解至20mL干燥的二氯甲烷中,然后用恒压滴液漏斗缓慢滴加至上述溶液中。搅拌24-72h。旋干,然后经柱色谱分离(洗脱剂为乙酸乙酯:石油醚:=1:5)从而得到目标化合物。表征如下:
1,3-噻吩丙酮:收率:56%。1H NMR(500MHz,CDCl3)δ7.19-7.13(m,2H),6.94(t,J=6.4Hz,2H),6.80(dd,J=4.9,0.9Hz,2H),3.63(s,4H).
实施例2
降糖药中间体的应用
将溶解在15mL无水THF中的1,3-噻吩丙酮(0.350g,1.57mmol)滴加到冷却的含有氢化钾(0.5g,12.2mmol)的THF(30mL,0℃)的溶液中。将碘甲烷(0.4mL,6.4mmol)逐滴加入到黄色悬浮液中并搅拌至室温。待悬浮液变白,然后回流直至观察到悬浮液变为橙色,然后将悬浮液冷却至0℃,滴加额外量的碘甲烷(0.15mL,2.4mmol),然后用水和乙醚萃取。醚层用硫酸镁干燥并减压蒸发。通过柱色谱(二氧化硅,CH3COOC2H5=10%,己烷=90%)纯化残余物,得到白色结晶粉末。表征如下:
2,4-二甲基-2,4-二(噻吩-3-基)戊-3-酮:收率:90%;熔点:76-78℃。1HNMR(500MHz,CDCl3)δ7.17(dd,J=4.96Hz,1H),6.84(d,J=2.9Hz,1H),6.76(dd,J=4.96Hz,1H),1.36(s,6H)。
实施例3
光电材料的应用
向1,3-噻吩丙酮(0.04g,0.14mmol)的丙酮(2mL)溶液中一次性加入10mL水/SDS溶液(2.5mM)。在搅拌的同时将空气吹到反应小瓶上,直至获得总体积为6mL的空气。加入额外的2mL水使总体积为8mL。将乳白色悬浮液置于距离中压Hg海诺威灯的距离(~10cm)处并搅拌,同时在光解室内保持4个恒定温度(约25℃)。在照射过程中,在不同时间取出少量各样品,并通过GC,NMR和X-RPD分析。照射在12小时后停止,然后过滤黄色沉淀,得到目标化合物。表征如下:
3-(2,3-二甲基-3-(噻吩-3-基)丁-2-基)噻吩:收率:70%;熔点:125-128℃。1HNMR(500HMz,CDCl3)δ7.14(dd,J=3.0,4.98Hz,1H),6.79(dd,J=3.0Hz,1H),6.77(dd,J=4.98Hz,1H)1.34(s,6H)。
以上所述,仅为本发明创造较佳的具体实施方式,但本发明创造的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明创造披露的技术范围内,根据本发明创造的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明创造的保护范围之内。
Claims (7)
1.一种1,3-杂环取代芳香酮的制备方法,其特征在于,该方法包括以下步骤:
S1.将DCC和DMAP加入到圆底烧瓶中,并加入干燥的二氯甲烷搅拌均匀;
S2.将杂环取代的芳香苯乙酸溶解在二氯甲烷溶液中滴加至步骤S1的反应液中,20~30℃反应24-72h;
S3.过滤除去步骤S2的沉淀,滤液旋蒸使用柱层析分离得到产品。
2.根据权利要求1所述的一种1,3-杂环取代芳香酮的制备方法,其特征在于,所述步骤S1中DCC和DMAP的摩尔比为1~10:1~2。
3.根据权利要求1所述的1,3-杂环取代芳香酮的制备方法,其特征在于,所述步骤S2中杂环取代的芳香苯乙酸摩尔数与DCC相等。
4.根据权利要求1所述的1,3-杂环取代芳香酮的制备方法,其特征在于,所述步骤S1中二氯甲烷与杂环取代的芳香苯乙酸的比例关系为杂环取代的芳香苯乙酸:二氯甲烷=1mmol:2~5mL。
5.根据权利要求1所述的1,3-杂环取代芳香酮的制备方法,其特征在于,所述步骤S2中二氯甲烷与杂环取代的芳香苯乙酸的比例关系为杂环取代的芳香苯乙酸:二氯甲烷=1mmol:4~8mL。
6.根据权利要求1所述的一种1,3-杂环取代芳香酮的制备方法,其特征在于,步骤S3中的洗脱剂为乙酸乙酯:石油醚=1:5。
7.如权利要求1所述的方法得到的产品在降糖药和光电结晶导体材料制备方面的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910380476.5A CN109970703A (zh) | 2019-05-08 | 2019-05-08 | 1,3-杂环取代芳香酮的制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910380476.5A CN109970703A (zh) | 2019-05-08 | 2019-05-08 | 1,3-杂环取代芳香酮的制备方法及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109970703A true CN109970703A (zh) | 2019-07-05 |
Family
ID=67073247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910380476.5A Pending CN109970703A (zh) | 2019-05-08 | 2019-05-08 | 1,3-杂环取代芳香酮的制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109970703A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114426533A (zh) * | 2021-12-23 | 2022-05-03 | 玉林师范学院 | 一种钌催化制备多芳基取代苯并噻吩的方法及应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103153300A (zh) * | 2010-08-11 | 2013-06-12 | 米伦纽姆医药公司 | 杂芳基化合物和其用途 |
-
2019
- 2019-05-08 CN CN201910380476.5A patent/CN109970703A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103153300A (zh) * | 2010-08-11 | 2013-06-12 | 米伦纽姆医药公司 | 杂芳基化合物和其用途 |
Non-Patent Citations (5)
Title |
---|
J. ARIAS-PARDILLA: "Reduction and Oxidation Doping Kinetics of an Electropolymerized Donor−Acceptor Low-Bandgap Conjugated Copolymer", 《J. PHYS. CHEM. B》 * |
JESSE P. WALDO, ET AL.: "Efficient Synthesis of Fluoren-9-ones by the Palladium-Catalyzed, Annulation of Arynes by 2-Haloarenecarboxaldehydes", 《J. ORG. CHEM.》 * |
MARINO J. E. RESENDIZ: "Photodecarbonylation of 1,3-Dithiophenyl Propanone: Using Nanocrystals to Overcome the Filtering Effect of Highly Absorbing Trace Impurities", 《ORG. LETT.》 * |
MARINO J. E. RESENDIZ: "Unexpected Solid-State Photochemistry of an α-Thiophenyl-α‘-Thiophenyl-S,S-dioxo-Substituted Ketone", 《J. ORG. CHEM.》 * |
徐威: "《药学细胞生物学》", 31 August 2015, 中国医药科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114426533A (zh) * | 2021-12-23 | 2022-05-03 | 玉林师范学院 | 一种钌催化制备多芳基取代苯并噻吩的方法及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103052635B (zh) | 合成苯并噻二唑化合物的方法 | |
DE112011104615B4 (de) | Organoborverbindung und Verfahren zum Herstellen derselben | |
CN107266348B (zh) | 联苯乙酮腙-3-吲哚甲醛西弗碱的制备、结构和用途 | |
Shen et al. | One‐pot synthesis of triarylmethanes via metal‐free reductive coupling of diaryl ketones, tosylhydrazide, and arylboronic acids | |
CN104803903B (zh) | 一种吡咯类衍生物及其合成方法和应用 | |
CN107141246A (zh) | 一种靛红衍生物的制备方法 | |
CN106632214A (zh) | 一种大麻酚类化合物的合成方法 | |
CN110818631A (zh) | 一种吡啶硫脲衍生物及其制备方法和应用 | |
CN110256451A (zh) | 一种苯并呋喃并[2,3-b]喹啉衍生物的合成方法 | |
CN109970703A (zh) | 1,3-杂环取代芳香酮的制备方法及应用 | |
CN102584784A (zh) | 一种2, 5-二取代噻吩类化合物的制备方法 | |
CN105820174B (zh) | 一种多取代噻吩并吲哚衍生物的制备方法 | |
CN108689892B (zh) | 3-磺酰化-二氢茚酮类化合物及其制备方法 | |
CN110092751B (zh) | 一种2-烃基喹啉的合成方法 | |
CN110590621B (zh) | 一种铜催化端炔合成1,2-双(芳基磺酰基)乙烯衍生物的方法 | |
CN115028645A (zh) | 双吲哚酮[螺]苯并二氢呋喃类化合物的合成方法 | |
CN108727323B (zh) | 一种氮杂环卡宾催化合成三氟甲基取代高异黄酮类化合物的方法 | |
CN107118147B (zh) | 联苯乙酮腙-3-乙酰基吲哚西弗碱的制备、结构和用途 | |
CN105622493B (zh) | 一种烯胺酮和醛串联反应合成全取代吡啶类化合物的方法 | |
CN104327025A (zh) | 一种4-芳基萘内酯类衍生物的制备方法 | |
CN114181182B (zh) | 一种多取代的4h-吡喃类化合物的合成方法 | |
CN113234067B (zh) | 2,5-二取代噻吩类化合物及其合成方法 | |
CN109988113A (zh) | 一种[60]富勒烯四氢喹啉衍生物的合成方法 | |
CN114560805B (zh) | 含氮杂环化合物及其中间体的合成方法 | |
CN104387363B (zh) | 一种全取代噻吩的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |